Zoom (ZM) Q2 2027 Earnings Call Transcript
Source: The Motley Fool
Zoom reported Q2 FY2027 revenue of $1.2772B (+4.9% YoY; +4.7% constant currency) and non-GAAP diluted EPS of $1.55 (+2c YoY), both above the high end of guidance. Enterprise revenue grew 7.8% YoY (62% of total revenue) with RPO rising 14% YoY to ~$4.5B, while non-GAAP operating margin fell to 40.0% (from 41.3%) as AI usage spiked. The company raised FY2027 guidance: revenue to $5.085B–$5.095B (+4.5% at midpoint), non-GAAP EPS to $6.08–$6.12, and free cash flow to $1.78B–$1.82B, alongside $352M of share repurchases during the quarter ($1.3B remaining). Management tempered Online growth outlook to flat for near-term factors (top-of-funnel discovery dynamics), but reiterated that Enterprise strength and AI monetization drive the raise.
Analysis
The real signal is not the headline growth rate; it is that enterprise monetization is broadening from a single-product communications vendor into a multi-workflow platform. That shifts the competitive fight from commoditized video seats into higher-ARPU, stickier land-and-expand motions where replacement risk rises for legacy phone, contact-center, and point AI workflow vendors. The second-order benefit is that every new module increases switching costs and gives Zoom more control over the customer conversation, but it also raises the compute bill and makes margin discipline the key tell.
Near term, the market will probably over-focus on the AI narrative and underweight the fact that the online funnel is softening while enterprise is doing the heavy lifting. If SMB discovery remains impaired, the company can still beat on mix, but headline growth stays constrained and the stock becomes a multiple story rather than an earnings compounding story. The main falsifier is a step-down in enterprise expansion: if NDR fails to clear 100% over the next 1-2 quarters or RPO stops converting into faster revenue, the re-acceleration thesis weakens.
Contrarian take: the consensus is likely underestimating how much of Zoom’s AI value can be sold as workflow automation rather than chatbot garnish. The flip side is that the stock is probably not cheap enough to ignore execution risk in AI unit economics; if usage keeps outpacing monetization, gross margin can leak another 50-100 bps before pricing catches up. In that sense, the next leg is less about product announcements and more about whether enterprise conversion plus capital returns can offset the online deceleration.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
Key Decisions for Investors
- Buy ZM on any 3-5% post-earnings pullback over the next 1-2 weeks; use a 6-12 month horizon and look for a rerate if Enterprise growth stays mid-to-high single digits and FCF remains above $1.8B. Risk/reward is attractive if the market starts assigning a premium to durable enterprise mix rather than treating ZM as a low-growth comms name.
- Use a ZM call-spread structure for the next 3-6 months rather than outright stock if you want to express upside while capping downside from AI margin noise. The trade works best if the next two quarters confirm that enterprise expansion, not online pricing, is driving the guide.
- Set a hard risk alert on ZM if gross margin falls below 78% or Enterprise NDR slips back below 98.5% in the next quarter; that would indicate AI cost pressure is outrunning monetization and the re-rating thesis is fading.
- For relative value, stay long ZM versus the broader enterprise software basket on dips, but avoid aggressive shorting of MSFT or GOOGL here; the better read-through is competitive pressure on niche UCaaS/CCaaS spend, not a broad-platform displacement trade.
More News
- ‘I told you so’: China’s chip sector is making breakthroughs—and U.S. export controls are the reasons why
- CoreWeave credit default swaps hit distress levels as investors sour on AI debt
- Giant Taiwanese chipmaker TSMC confirms it’s in talks with Elon Musk to join ‘Terafab’ complex in Texas: ‘The AI market continues to be very strong’
- Suddenly, Wall Street is worried that the U.S. economy is more ‘vulnerable’ than it looks
- Taiwan to curb AI chip sales to China for more U.S. alignment- Bloomberg
- TSMC chip capacity is ‘fierce’ battleground for AI customers, amid record quarter
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Introducing AllMind: A New Data & AI Workspace for Institutional Investors
- AI Tools for Private Equity Due Diligence: A Buyer Workflow